What you should know:
1. The Rotium is a bioresorbable scaffold that sits between the repaired tendon and bone to enhance healing.
2. Fort Collins-based Colorado State University researchers tested the product on sheep models. The sheep demonstrated, “tremendous improvement” in tendon strength when treated with the Rotium.
3. This is Atreon’s second regenerative product to earn FDA clearance. The first was the Phoenix Wound Matrix, an absorbable synthetic graft that mimics a patient’s extracellular matrix.
https://www.renovoderm.tech/phoenix
4. “To receive the second FDA clearance in a year, in two different clinical areas, tells us we are on the right track in developing our regeneration technology platform,” said Atreon CEO Ross Kayuha.
More articles on practice management:
Geisinger, Medacta launch lifetime guarantee for knee replacements: 4 details
Stryker strengthens sports medicine line with up to $220M acquisition: 5 notes
RTI Surgical acquires Paradigm Spine: 4 things to know
